Cargando…
Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model
The blood–brain barrier (BBB) is necessary for maintaining brain homeostasis, but it also represents a major challenge for drug delivery to the brain tumors. A suitable in vivo Glioblastoma Multiforme (GBM) model is needed for efficient testing of BBB crossable pharmaceuticals. In this study, we fir...
Autores principales: | Zeng, Anqi, Ye, Tinghong, Cao, Dan, Huang, Xi, Yang, Yu, Chen, Xiuli, Xie, Yongmei, Yao, Shaohua, Zhao, Chengjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662771/ https://www.ncbi.nlm.nih.gov/pubmed/29085081 http://dx.doi.org/10.1038/s41598-017-14766-2 |
Ejemplares similares
-
Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish
por: Ai, Xiaolin, et al.
Publicado: (2022) -
Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts
por: Koessinger, Anna L., et al.
Publicado: (2020) -
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
por: Patrizii, Michele, et al.
Publicado: (2018) -
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
por: Pacioni, Simone, et al.
Publicado: (2017) -
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
por: Gamboa, Christian Moya, et al.
Publicado: (2021)